title: [Attention deficit disorder with hyperactivity in children: diagnosis and therapeutic management].
abstract: Criteria of attention deficit disorder with hyperactivity are defined in DSM IV and CIM 10. This syndrome is a model associating in the same entity, psychogenic and neurobiologic mechanisms. The diagnosis requires a rigorous analysis of the semiology, circumstances, and factors. Treatment cannot be simply reduced to the prescription of a psychostimulant drug or clonidine and must be adapted for each patient. Support of parents and teachers, and psychopedagogic and learning disorders management are described.
authors.affiliation: Service de neuropédiatrie, hôpital Roger-Salengro, CHRU, Lille, France.
authors.forename: L
authors.initials: L
authors.lastname: Vallée
mesh_terms: D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D003000:Clonidine / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004311:Double-Blind Method; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D011613:Psychotherapy; D011795:Surveys and Questionnaires; D013566:Sympathomimetics / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000316:Adrenergic alpha-Agonists; D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D013566:Sympathomimetics; D008774:Methylphenidate; D003000:Clonidine